Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-22 Purchase | 2022-11-28 4:33 pm | Lipocine Inc. | LPCN | Papapetropoulos Spyros Director | 21,739 | $0.47 | $10,217 | 21,739 (Direct) | View |
| 2022-11-18 Sale | 2022-11-22 9:45 pm | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 300 | $14 | $4,200 | 153,604 (Direct) | View |
| 2022-05-03 Purchase | 2022-05-04 07:00 am | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 4,000 | $3.3978 | $13,591 | 4,000 (Direct) | View |
| 2021-03-11 Purchase | 2021-03-15 3:24 pm | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 5,975 | $5.06 | $30,233 | 15,975 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-07-08 06:10 am | N/A N/A | BIONOMICS LIMITED | BNOX | Papapetropoulos Spyros Chief Executive Officer | 0 | $0 | 33,066,955 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:48 pm | 2025-06-05 2034-06-05 | Lipocine Inc. | LPCN | Papapetropoulos Spyros Director | 1,764 | $7.05 | 5,410 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:37 pm | 2024-05-10 2033-05-10 | Lipocine Inc. | LPCN | Papapetropoulos Spyros Director | 30,000 | $0.2656 | 62,000 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-22 9:45 pm | N/A 2030-11-18 | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 300 | $0 | 153,604 (Direct) | View |
| 2022-11-18 Exercise | 2022-11-22 9:45 pm | N/A N/A | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyros Chief Medical Officer | 300 | $1.89 | 153,604 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 11:34 am | 2023-06-08 2032-06-08 | Lipocine Inc. | LPCN | Papapetropoulos Spyros Director | 22,000 | $0.92 | 32,000 (Direct) | View |
| 2022-04-11 Option Award | 2022-04-12 5:00 pm | 2023-04-11 2032-04-11 | Lipocine Inc. | LPCN | Papapetropoulos Spyros Director | 10,000 | $1.16 | 10,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:05 pm | N/A 2032-03-01 | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer | 75,500 | $0 | 75,500 (Direct) | View |
Ownership | 2022-01-06 8:31 pm | N/A 2030-11-18 | Vigil Neuroscience Inc. | VIGL | Papapetropoulos Spyridon Chief Medical Officer | 0 | $0 | 293,004 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 20,975 | $0 | 0 (Direct) | View |
| 2021-11-24 Disposition | 2021-11-24 4:09 pm | N/A 2030-11-21 | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 30,000 | $0 | 0 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:16 pm | 2022-06-02 2031-06-01 | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 15,000 | $0 | 30,975 (Direct) | View |
| 2020-11-22 Option Award | 2020-11-24 5:57 pm | N/A 2030-11-21 | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2020-11-24 5:52 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 0 | $0 | 0 (Direct) | View |